The efficacy and safety of new combined medicinal product in the treatment of influenza: The results of a multicenter randomized comparative clinical trial Source: Annual Congress 2013 –Viral infections: what is new? Year: 2013
Development of RSV antiviral treatment: where are we? Source: International Congress 2019 – Respiratory syncytial virus infections throughout life Year: 2019
Antiviral therapy – the evidence base and clinical trials Source: International Congress 2015 – PG11 Emerging infectious diseases and pandemic planning Year: 2015
Influenza: vaccination and treatment Source: Eur Respir J 2001; 17: 1282-1293 Year: 2001
The results of a randomized clinical trial of the efficacy of the antibodies-based drug in influenza and acute respiratory viral infections in children Source: International Congress 2019 – New insights into childhood infections: from viral bronchiolitis to bronchiolitis obliterans Year: 2019
Influenza A/H1N1 vaccination in lung a transplant program: Coverage, safety and clinical effectiveness during the pandemic 2009/2010 Source: Annual Congress 2010 - Pre-operative evaluation and post-operative problems after lung transplantation Year: 2010
Influenza surveillance and vaccination: new developments Source: International Congress 2017 – PG17 Infectious disease challenges in community-acquired pneumonia and tuberculosis: improving your clinical practice Year: 2017
Impact of influenza vaccination in patients with CAP Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia Year: 2009
Clinical efficacy of pneumococcal vaccine in COPD patients. preliminary results Source: Eur Respir J 2003; 22: Suppl. 45, 408s Year: 2003
Pandemic influenza: using evidence on vaccines and antivirals for clinical decisions and policy making Source: Eur Respir J 2006; 27: 661-663 Year: 2006
Quality and methodology of clinical practice guidelines on antiviral pharmacotherapy for COVID-19 during the early phase of the pandemic Source: Virtual Congress 2021 – COVID - 19: lessons learned Year: 2021
Seasonal influenza vaccine effectiveness in people with asthma: A systematic review Source: International Congress 2016 – Clinical studies in asthma and immunology Year: 2016
Late-breaking abstract: Relationship of asthma to outcome in influenza A/H1N1 2009 infection: FLU-CIN cohort study Source: Annual Congress 2011 - New aspects in prevention and treatment of community-acquired pneumonia and lower respiratory tract infections Year: 2011
Efficacy and safety of new drugs for M/XDR-TB: what have we learned from observational studies? Source: International Congress 2019 – Recent developments and future perspectives in the diagnosis and treatment of tuberculosis Year: 2019
ARDS in patients with 2009 H1N1 influenza: Preliminary data Source: Annual Congress 2010 - Pulmonary infections and sepsis Year: 2010
Effects of statin therapy on the risk of serious outcomes during influenza epidemics Source: Eur Respir J 2006; 28: Suppl. 50, 154s Year: 2006
Safety and immunogenicity of a dose-sparing, trivalent inactivated seasonal influenza vaccine containing an advax adjuvant – a phase 1/2 randomised controlled trial Source: Annual Congress 2008 - Community-acquired pneumonia: prognosis, complications and prevention Year: 2008
Late Breaking Abstract - Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof of concept clinical trial Source: Virtual Congress 2021 – Highlights in COVID-19 diagnosis and treatment Year: 2021